Featured Research Search Results

Evaluate the Benefit of Adding ART6043 to Olaparib for HER2-Negative Metastatic or Advanced Breast Cancer and a gBRCA Mutation (POLKA)

Clinicaltrials.gov identifier:
NCT05898399

Treatment
Metastatic breast cancer treatment study

Phase 1/2

A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone or Darolutamide (TALENT)

Clinicaltrials.gov identifier:
NCT06844383

Treatment
Study for metastatic castration-resistant prostate cancer with an HRR mutation

Phase 2

ERADICATE: Hormone and Targeted Therapy for HR+/HER2-Low Advanced Breast Cancer

Clinicaltrials.gov identifier:
NCT07198724

Treatment
Study of hormone and targeted therapy for advanced breast cancer

Phase 1/2

Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

Clinicaltrials.gov identifier:
NCT06195306

Prevention
Prevention study for postmenopausal women at increased risk for breast cancer

Phase 2

IGNITE-TX - Identifying Individuals for Genetic Testing for Familial Cancer

Clinicaltrials.gov identifier:
NCT07318363

Prevention
People with a genetic mutation in BRCA1, BRCA2 or Lynch syndrome who have relatives who have not been tested

Phase 3

Research Study on the Genetics of Breast Cancer

Clinicaltrials.gov identifier:
NCT06773897

Surveys, Registries, Interviews
A registry for anyone aged 18 and older who lives in the United States

ShareForCures®: Komen's People-Powered, Data-Driven Breast Cancer Research Registry

Clinicaltrials.gov identifier:
NCT05654246

Surveys, Registries, Interviews
Registry for anyone diagnosed with breast cancer

Survey for Caregivers or Supporters of Women Diagnosed With Breast Cancer Before Age 45

Surveys, Registries, Interviews
Survey of caregivers of women with breast cancer diagnosed before 45

FIT Testing for Colorectal Cancer Screening in People with Lynch Syndrome

Clinicaltrials.gov identifier:
NCT06898996

Prevention
Colon cancer screening study for people with Lynch syndrome

The ZERO Prostate Cancer BEACON (Barriers, Education, Awareness, Care, Outcomes, and Needs) Survey

Surveys, Registries, Interviews
BEACON is a survey designed to build a comprehensive understanding of the state of prostate cancer awareness and care from the perspectives of men at risk, patient/survivors, caregivers, and healthcare professionals 21 and older.

Virtual Exercise Classes for Adult Cancer Survivors (SURGE)

Clinicaltrials.gov identifier:
NCT07290309

Quality of Life
Exercise study for people diagnosed within the past 5 years

Using a Computer Model to Identify Treatment Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)

Clinicaltrials.gov identifier:
NCT07067138

Treatment
Treatment study for people with metastatic breast cancer

Previvors’ Perceptions of Preimplantation Genetic Testing (PGT-M) After a Cancer Predisposition Diagnosis

Surveys, Registries, Interviews
Interview for eligible previvors

Treating Advanced MSI-High or dMMR Cancers Using the Targeted Therapy MOMA-341 Given Alone or In Combination with Standard Therapies

Clinicaltrials.gov identifier:
NCT06974110

Treatment
Treatment study for people with advanced or metastatic cancers

Phase 1

Beyond a "Women's Gene": Assessing the Perception and Satisfaction Following Genetic Counseling for Males with a BRCA Mutation

Surveys, Registries, Interviews
Survey for men with a BRCA1 or BRCA2 genetic mutation

Family Communication After Genetic Testing for Colorectal Cancer

Clinicaltrials.gov identifier:
NCT07143487

Prevention
Family communication study after colorectal cancer diagnosis

Understanding Risk Factors for Stomach Cancer in People with Inherited Mutations

Surveys, Registries, Interviews
Online survey on stomach cancer risk for people with an inherited mutation in genes that are linked to an increased risk of cancer

REKINDLE: Your Ability to Cope With a Life-Changing Medical Diagnosis

Clinicaltrials.gov identifier:
NCT07002034

Quality of Life
Study for those experiencing mental health struggles due to a diagnosis of cancer or other medical illness

Phase 2